Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Mertens

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Nucleic Acids Research|February 29, 2020
HDAC3 functions as a positive regulator in Notch signal transductionFrancesca Ferrante, Benedetto Daniele Giaimo, Marek Bartkuhn, et al.
Haematologica|August 18, 2010
Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical riskDirk Winkler, Christof Schneider, Manuela Zucknick, et al.
Blood|July 10, 2025
A noncoding mutation in the NOTCH1 gene initiates oncogenic NOTCH signaling via wild-type NICD stabilization in CLLMin Guo, Tugba Memis, Alena Sophie Ehrmann, et al.
Blood|July 4, 2013
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSGAndrea Schnaiter, Peter Paschka, Marianna Rossi, et al.
Neoplasia (New York, N.Y.)|July 14, 2011
Matrix-dependent regulation of AKT in Hepsin-overexpressing PC3 prostate cancer cellsStephanie M Wittig-Blaich, Lukasz A Kacprzyk, Thorsten Eismann, et al.
Genome Research|September 12, 2023
Nucleosome repositioning in chronic lymphocytic leukemiaKristan V Piroeva, Charlotte McDonald, Charalampos Xanthopoulos, et al.
Haematologica|March 18, 2021
Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patientsJohannes Bloehdorn, Julia Krzykalla, Karlheinz Holzmann, et al.
The Journal of Clinical Investigation|December 4, 2012
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signalingKatrin Faber, Lars Bullinger, Christine Ragu, et al.
Gut Microbes|November 22, 2022
Atypical enteropathogenic <i>E. coli</i> are associated with disease activity in ulcerative colitisMaximilian Baumgartner, Rebecca Zirnbauer, Sabine Schlager, et al.
Cancer Discovery|May 11, 2021
Discovery of Candidate DNA Methylation Cancer Driver GenesHeng Pan, Loïc Renaud, Ronan Chaligne, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Nucleic Acids Research|February 29, 2020
HDAC3 functions as a positive regulator in Notch signal transductionFrancesca Ferrante, Benedetto Daniele Giaimo, Marek Bartkuhn, et al.
Haematologica|August 18, 2010
Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical riskDirk Winkler, Christof Schneider, Manuela Zucknick, et al.
Blood|July 10, 2025
A noncoding mutation in the NOTCH1 gene initiates oncogenic NOTCH signaling via wild-type NICD stabilization in CLLMin Guo, Tugba Memis, Alena Sophie Ehrmann, et al.
Blood|July 4, 2013
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSGAndrea Schnaiter, Peter Paschka, Marianna Rossi, et al.
Neoplasia (New York, N.Y.)|July 14, 2011
Matrix-dependent regulation of AKT in Hepsin-overexpressing PC3 prostate cancer cellsStephanie M Wittig-Blaich, Lukasz A Kacprzyk, Thorsten Eismann, et al.
Genome Research|September 12, 2023
Nucleosome repositioning in chronic lymphocytic leukemiaKristan V Piroeva, Charlotte McDonald, Charalampos Xanthopoulos, et al.
Haematologica|March 18, 2021
Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patientsJohannes Bloehdorn, Julia Krzykalla, Karlheinz Holzmann, et al.
The Journal of Clinical Investigation|December 4, 2012
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signalingKatrin Faber, Lars Bullinger, Christine Ragu, et al.
Gut Microbes|November 22, 2022
Atypical enteropathogenic <i>E. coli</i> are associated with disease activity in ulcerative colitisMaximilian Baumgartner, Rebecca Zirnbauer, Sabine Schlager, et al.
Cancer Discovery|May 11, 2021
Discovery of Candidate DNA Methylation Cancer Driver GenesHeng Pan, Loïc Renaud, Ronan Chaligne, et al.
Pageof 10